Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marianne Budde"'
Autor:
Lars R. Perk, Paul Jurek, Guus A.M.S. van Dongen, Maria J.W.D. Vosjan, Marianne Budde, Gerard W. M. Visser, Garry E. Kiefer
Publikováno v:
Perk, L R, Vosjan, M J W D, Visser, G W M, Budde, M, Jurek, P, Kiefer, G E & van Dongen, G A M S 2010, ' p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 2, pp. 250-259 . https://doi.org/10.1007/s00259-009-1263-1
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 250-259. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 37(2), 250-259. Springer Verlag
Purpose Immuno-PET is an emerging imaging tool for the selection of high potential antibodies (mAbs) for imaging and therapy. The positron emitter zirconium-89 (89Zr) has attractive characteristics for immuno-PET with intact mAbs. Previously, we have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7259d044098b3a88129197efabf9f83b
https://doi.org/10.1007/s00259-009-1263-1
https://doi.org/10.1007/s00259-009-1263-1
Autor:
C. René Leemans, Bernard M. Tijink, Marijke Stigter-van Walsum, Ludger Dinkelborg, Reina W. Kloet, Guus A.M.S. van Dongen, Gerard W. M. Visser, Lars R. Perk, Dario Neri, Marianne Budde
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 36(8), 1235-1244. Springer Verlag
Tijink, B M, Perk, L R, Budde, M, Stigter-van Walsum, M, Visser, G W M, Kloet, R W, Dinkelborg, L M, Leemans, C R, Neri, D & van Dongen, G A M S 2009, ' I-124-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of I-131-L19-SIP radioimmunotherapy ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 8, pp. 1235-1244 . https://doi.org/10.1007/s00259-009-1096-y
European Journal of Nuclear Medicine and Molecular Imaging
Tijink, B M, Perk, L R, Budde, M, Stigter-van Walsum, M, Visser, G W M, Kloet, R W, Dinkelborg, L M, Leemans, C R, Neri, D & van Dongen, G A M S 2009, ' I-124-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of I-131-L19-SIP radioimmunotherapy ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 8, pp. 1235-1244 . https://doi.org/10.1007/s00259-009-1096-y
European Journal of Nuclear Medicine and Molecular Imaging
The human monoclonal antibody (MAb) fragment L19-SIP is directed against extra domain B (ED-B) of fibronectin, a marker of tumour angiogenesis. A clinical radioimmunotherapy (RIT) trial with (131)I-L19-SIP was recently started. In the present study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e286e88e7ea642f41f467f6e0a1eb053
https://doi.org/10.1007/s00259-009-1096-y
https://doi.org/10.1007/s00259-009-1096-y
Autor:
Gerald A. Ruiter, Erna Peters, Arnold H. van der Luit, Harry Bartelink, Pieter Koolwijk, Stefan R. Vink, Shuraila F. Zerp, Wim J. van Blitterswijk, Marianne Budde, Marcel Verheij, Daphne de Jong
Publikováno v:
Zerp, S F, Vink, S R, Ruiter, G A, Koolwijk, P, Peters, E, van der Luit, A H, de Jong, D, Budde, M, Bartelink, H, van Blitterswijk, W J & Verheij, M 2008, ' Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents ', Anti-Cancer Drugs, vol. 19, no. 1, pp. 65-75 . https://doi.org/10.1097/CAD.0b013e3282f16d36
Anti-Cancer Drugs, 19(1), 65-75. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 1, 19, 65-75
Anti-Cancer Drugs, 19(1), 65-75. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 1, 19, 65-75
Synthetic alkylphospholipids (APLs), such as edelfosine, miltefosine and perifosine, constitute a new class of antineoplastic compounds with various clinical applications. Here we have evaluated the antiangiogenic properties of APLs. The sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e4e6fc15234bca062922e3b60379dc
https://doi.org/10.1097/cad.0b013e3282f16d36
https://doi.org/10.1097/cad.0b013e3282f16d36
Publikováno v:
Biochemical Journal. 374:747-753
The synthetic alkyl-lysophospholipid (ALP), Et-18-OCH3 (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine), can induce apoptosis in tumour cells. Unlike conventional chemotherapeutic drugs, ALP acts at the cell-membrane level. We have reported pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e99ac4cfe6331bf5d30c2394eaff59
https://doi.org/10.1042/bj20030179
https://doi.org/10.1042/bj20030179
Publikováno v:
Journal of Biological Chemistry. 277:39541-39547
The synthetic alkyl-lysophospholipid (ALP), 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine, is an antitumor agent that acts on cell membranes and can induce apoptosis. We investigated how ALP is taken up by cells, how it affects de novo biosyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8827c7ed11ff0af923a08916bfa7e7
https://doi.org/10.1074/jbc.m203176200
https://doi.org/10.1074/jbc.m203176200
Autor:
Garry E. Kiefer, Lars R. Perk, Maria J.W.D. Vosjan, Paul Jurek, Gerard W. M. Visser, Marianne Budde, Guus A.M.S. van Dongen
Publikováno v:
Vosjan, M J W D, Perk, L R, Visser, G W M, Budde, M, Jurek, P, Kiefer, G E & van Dongen, G A M S 2010, ' Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine ', Nature Protocols, vol. 5, no. 4, pp. 739-743 . https://doi.org/10.1038/nprot.2010.13
Nature Protocols, 5(4), 739-743. Nature Publishing Group
Nature Protocols, 5(4), 739-743. Nature Publishing Group
The positron emitter zirconium-89 ((89)Zr) has very attractive properties for positron emission tomography (PET) imaging of intact monoclonal antibodies (mAbs) using immuno-PET. This protocol describes the step-by-step procedure for the facile radiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e06da66025ea0fda382f5c97cfb023b
https://research.vumc.nl/en/publications/49d011ac-0b1f-42f5-bb6a-7bef2fd00b89
https://research.vumc.nl/en/publications/49d011ac-0b1f-42f5-bb6a-7bef2fd00b89
Autor:
Garry E. Kiefer, Marianne Budde, Paul Jurek, Maria J.W.D. Vosjan, Lars R. Perk, Gerard W. M. Visser, Guus A.M.S. van Dongen
Publikováno v:
Protocol Exchange.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fadf234c9c7ae02ff777459334e28e57
https://doi.org/10.1038/nprot.2008.22
https://doi.org/10.1038/nprot.2008.22
Autor:
Bernard M. Tijink, Toon Laeremans, Hans de Haard, Torsten Dreier, Guus A.M.S. van Dongen, Marijke Stigter-van Walsum, C. René Leemans, Marianne Budde
Publikováno v:
Tijink, B M, Laeremans, T, Budde, M, Stigter-van, W M, Dreier, T, de Haard, H J, Leemans, C R & van Dongen, G A M S 2008, ' Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology ', Molecular Cancer Therapeutics, vol. 7, no. 8, pp. 2288-2297 . https://doi.org/10.1158/1535-7163.MCT-07-2384
Molecular Cancer Therapeutics, 7(8), 2288-2297. American Association for Cancer Research Inc.
Molecular Cancer Therapeutics, 7(8), 2288-2297. American Association for Cancer Research Inc.
The approximately 15-kDa variable domains of camelid heavy-chain-only antibodies (called Nanobodies) can easily be formatted as multivalent or multispecific single-chain proteins. Because of fast excretion, however, they are less suitable for therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebff925b5e39eed83b6df8a4a3f83931
https://research.vumc.nl/en/publications/c600da2c-f702-463f-ac48-3de93ba160c1
https://research.vumc.nl/en/publications/c600da2c-f702-463f-ac48-3de93ba160c1
Autor:
Bernard M, Tijink, Dario, Neri, C René, Leemans, Marianne, Budde, Ludger M, Dinkelborg, Marijke, Stigter-van Walsum, Luciano, Zardi, Guus A M S, van Dongen
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(7)
The extra domain B of fibronectin (ED-B) is a marker of tumor angiogenesis. The human monoclonal antibody (mAb) L19-SIP (approximately 80 kDa; SIP is "small immunoprotein") has been selected for targeting of ED-B. The aim of this study was to evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96a8f850028ebdb82763a51b59aea70e
https://pubmed.ncbi.nlm.nih.gov/16818938
https://pubmed.ncbi.nlm.nih.gov/16818938
Autor:
Johannes W. J. Bijlsma, Johan M. TeKoppele, Marianne Budde, Jeroen DeGroot, Nicole Verzijl, Floris P J G Lafeber
Publikováno v:
Experimental cell research, 266(2), 303-310. Academic Press Inc.
Experimental Cell Research, 2, 266, 303-310
Experimental Cell Research, 2, 266, 303-310
The integrity of the collagen network is essential for articular cartilage to fulfill its function in load support and distribution. Damage to the collagen network is one of the first characteristics of osteoarthritis. Since extensive collagen damage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa5604e860da3131aa3202d7ff3e4c2
https://pure.amc.nl/en/publications/accumulation-of-advanced-glycation-end-products-decreases-collagen-turnover-by-bovine-chondrocytes(548a19a4-98e0-4812-88ad-efe3c1a47f90).html
https://pure.amc.nl/en/publications/accumulation-of-advanced-glycation-end-products-decreases-collagen-turnover-by-bovine-chondrocytes(548a19a4-98e0-4812-88ad-efe3c1a47f90).html